The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
Abstract
Clinical evidence suggests that cellular immunity is involved in controlling human immunodeficiency virus–1 (HIV-1) replication. An animal model of acquired immune deficiency syndrome (AIDS), the simian immunodeficiency virus (SIV)–infected rhesus monkey, was used to show that virus replication is not controlled in monkeys depleted of CD8 + lymphocytes during primary SIV infection. Eliminating CD8 + lymphocytes from monkeys during chronic SIV infection resulted in a rapid and marked increase in viremia that was again suppressed coincident with the reappearance of SIV-specific CD8 + T cells. These results confirm the importance of cell-mediated immunity in controlling HIV-1 infection and support the exploration of vaccination approaches for preventing infection that will elicit these immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495
Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA
Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., et al. (1998) · Science · doi:10.1126/science.279.5359.2103 · Cited by 1,383
CD8 + Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus Replication
Walker, C. M., Moody, D. J., Stites, D. P., & Levy, J. A. (1986) · Science · doi:10.1126/science.2431484 · Cited by 990
Musey, L., Hughes, J., Schacker, T., Shea, T., Corey, L., & McElrath, M. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710303371803 · Cited by 518
Matano, T., Shibata, R., Siemon, C., Connors, M., Lane, H. C., & Martin, M. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.164-169.1998 · Cited by 487
Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response
Phillips, A. N. (1996) · Science · doi:10.1126/science.271.5248.497 · Cited by 328
Kuroda, M. J., Schmitz, J. E., Barouch, D. H., Craiu, A., Allen, T. M., Sette, A., Watkins, D. I., Forman, M. A., & Letvin, N. L. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1373 · Cited by 262
Self-citationReimann, K. A., Tenner-Racz, K., Racz, P., Montefiori, D. C., Yasutomi, Y., Lin, W., Ransil, B. J., & Letvin, N. L. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2362-2370.1994 · Cited by 252
Self-citationTenner-Racz, K., Stellbrink, H.-J., van Lunzen, J., Schneider, C., Jacobs, J.-P., Raschdorff, B., Großschupff, G., Steinman, R. M., & Racz, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.949 · Cited by 187
Self-citationSeth, A., Ourmanov, I., Kuroda, M. J., Schmitz, J. E., Carroll, M. W., Wyatt, L. S., Moss, B., Forman, M. A., Hirsch, V. M., & Letvin, N. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10112 · Cited by 100
Self-citation
Research works printed but not linked: 6
- Rinaldo C., et al., ibid. 69, 5838 (1995);
- N. L. Letvin and R. C. Desrosiers Eds. Current Topics in Microbiology and Immunology vol. 188 Simian Immunodeficiency Virus (Springer-Verlag Berlin 1994). · doi:10.1007/978-3-642-78536-8
- Rhesus monkeys in the primary and chronic SIV infection experiments were administered either the mouse-human chimeric monoclonal antibody to CD8 (cM-T807) or a control chimeric monoclonal antibody specific for respiratory syncytial virus (chimeric 1129; MedImmune Gaithersburg MD). Antibodies were given intravenously at 3 to 5 mg of antibody per kilogram of body weight three times over a 4- or 7-day period. For the primary infection experiment antibody treatments were initiated either 4 days before or 6 days after intravenous inoculation with about 20 animal infectious doses of SIVmac strain 251. Treatments with antibody CD8 resulted in CD8 + lymphocyte depletion during peak SIVmac viremia. In the chronic infection experiment monkeys were administered monoclonal antibodies >9 months after mucosal infection with SIVmac strain 251. All animals were maintained in accordance with the guidelines of the Committee on Animals for the Harvard Medical School and the Guide for the Care and Use of Laboratory Animals (National Research Council National Academic Press Washington DC 1996).
- Neville D. M., et al., J. Immunother. Emphasis Tumor Immunol. 19, 85 (1996). · doi:10.1097/00002371-199603000-00001
- Chakrabarti L., Cumont M.-C., Montagnier L., Hurrel B., J. Virol. 68, 6634 (1994); · doi:10.1128/jvi.68.10.6634-6643.1994
- Watson A., et al., ibid. 71, 284 (1997).
Cited by
Items 101–131 of 131
Casimiro, D. R., Wang, F., Schleif, W. A., Liang, X., Zhang, Z.-Q., Tobery, T. W., Davies, M.-E., McDermott, A. B., O'Connor, D. H., Fridman, A., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15547-15555.2005 · Cited by 271
Gea-Banacloche, J. C., Migueles, S. A., Martino, L., Shupert, W. L., McNeil, A. C., Sabbaghian, M. S., Ehler, L., Prussin, C., Stevens, R., Lambert, L., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.1082 · Cited by 267
Wolint, P., Betts, M. R., Koup, R. A., & Oxenius, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031799 · Cited by 265
Landais, E., Huang, X., Havenar-Daughton, C., Murrell, B., Price, M. A., Wickramasinghe, L., Ramos, A., Bian, C. B., Simek, M., Allen, S., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005369 · Cited by 265
Kuroda, M. J., Schmitz, J. E., Charini, W. A., Nickerson, C. E., Lifton, M. A., Lord, C. I., Forman, M. A., & Letvin, N. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5127 · Cited by 265
Self-citationGoing Wild: Lessons from Naturally Occurring T-Lymphotropic Lentiviruses
VandeWoude, S., & Apetrei, C. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00009-06 · Cited by 263
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity
Flores-Villanueva, P. O., Yunis, E. J., Delgado, J. C., Vittinghoff, E., Buchbinder, S., Leung, J. Y., Uglialoro, A. M., Clavijo, O. P., Rosenberg, E. S., Kalams, S. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071548198 · Cited by 263
Allen, T. M., Altfeld, M., Yu, X. G., O'Sullivan, K. M., Lichterfeld, M., Le Gall, S., John, M., Mothe, B. R., Lee, P. K., Kalife, E. T., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.7069-7078.2004 · Cited by 261
An HIV Vaccine — Evolving Concepts
Johnston, M. I., & Fauci, A. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra066267 · Cited by 257
Goulder, P. J. R., Altfeld, M. A., Rosenberg, E. S., Nguyen, T., Tang, Y., Eldridge, R. L., Addo, M. M., He, S., Muckerjee, J. S., Phillips, M. N., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.181 · Cited by 255
Harnessing innate immune pathways for therapeutic advancement in cancer
Hu, A., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01765-9 · Cited by 255
Priddy, F. H., Brown, D., Kublin, J., Monahan, K., Wright, D. P., Lalezari, J., Santiago, S., Marmor, M., Lally, M., Novak, R. M., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587993 · Cited by 253
Collier, J. L., Weiss, S. A., Pauken, K. E., Sen, D. R., & Sharpe, A. H. (2021) · Nature Immunology · doi:10.1038/s41590-021-00949-7 · Cited by 237
Poor Translatability of Biomedical Research Using Animals — A Narrative Review
Marshall, L. J., Bailey, J., Cassotta, M., Herrmann, K., & Pistollato, F. (2023) · Alternatives to Laboratory Animals · doi:10.1177/02611929231157756 · Cited by 219
Williams, D. W., Eugenin, E. A., Calderon, T. M., & Berman, J. W. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0811394 · Cited by 212
Williams, K., Alvarez, X., & Lackner, A. A. (2001) · Glia · doi:10.1002/glia.1105 · Cited by 190
Premature ageing of the immune system: the cause of AIDS?
Appay, V., & Rowland-Jones, S. L. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02338-4 · Cited by 173
SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 + T cell responses
Agerer, B., Koblischke, M., Gudipati, V., Montaño-Gutierrez, L. F., Smyth, M., Popa, A., Genger, J.-W., Endler, L., Florian, D. M., Mühlgrabner, V., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg6461 · Cited by 172
Reynolds, M. R., Rakasz, E., Skinner, P. J., White, C., Abel, K., Ma, Z.-M., Compton, L., Napoé, G., Wilson, N., Miller, C. J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.9228-9235.2005 · Cited by 168
“(ii) CD8 depletion results in high-level viral replication (18, 25 ).”
BackgroundKidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted
Tilstra, J. S., Avery, L., Menk, A. V., Gordon, R. A., Smita, S., Kane, L. P., Chikina, M., Delgoffe, G. M., & Shlomchik, M. J. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120859 · Cited by 149
Persistent cellular immunity to SARS-CoV-2 infection
Breton, G., Mendoza, P., Hägglöf, T., Oliveira, T. Y., Schaefer-Babajew, D., Gaebler, C., Turroja, M., Hurley, A., Caskey, M., & Nussenzweig, M. C. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202515 · Cited by 129
CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques
Liu, J., Yu, J., McMahan, K., Jacob-Dolan, C., He, X., Giffin, V., Wu, C., Sciacca, M., Powers, O., Nampanya, F., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abq7647 · Cited by 132
Self-citationKinetics of Virus-Specific CD8+T Cells and the Control of Human Immunodeficiency Virus Infection
Davenport, M. P., Ribeiro, R. M., & Perelson, A. S. (2004) · Journal of Virology · doi:10.1128/jvi.78.18.10096-10103.2004 · Cited by 101
Cellular and molecular mechanisms of CD8(+) T cell differentiation, dysfunction and exhaustion
Verdon, D. J., Mulazzani, M., & Jenkins, M. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197357 · Cited by 98
Moyo, N., Vogel, A. B., Buus, S., Erbar, S., Wee, E. G., Sahin, U., & Hanke, T. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.10.010 · Cited by 94
Buckner, C. M., Luers, A. J., Calderon, T. M., Eugenin, E. A., & Berman, J. W. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9017-3 · Cited by 88
Clonal lineage tracing reveals mechanisms skewing CD8+ T cell fate decisions in chronic infection
Kasmani, M. Y., Zander, R., Chung, H. K., Chen, Y., Khatun, A., Damo, M., Topchyan, P., Johnson, K. E., Levashova, D., Burns, R., et al. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20220679 · Cited by 87
A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression
Myers, L. M., Tal, M. C., Torrez Dulgeroff, L. B., Carmody, A. B., Messer, R. J., Gulati, G., Yiu, Y. Y., Staron, M. M., Angel, C. L., Sinha, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08637-9 · Cited by 66
T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases
McKinney, E. F., & Smith, K. G. (2016) · Immunology & Cell Biology · doi:10.1038/icb.2016.81 · Cited by 36
Takeda, A., Igarashi, H., Kawada, M., Tsukamoto, T., Yamamoto, H., Inoue, M., Iida, A., Shu, T., Hasegawa, M., & Matano, T. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.074 · Cited by 28
Manoussaka, M. S., Berry, N., Ferguson, D., Stebbings, R., Robinson, M., Ham, C., Page, M., Li, B., Das, A. T., Berkhout, B., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-59 · Cited by 16
Metadata
- Authors
- Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., Racz, P., Tenner-Racz, K., Dalesandro, M., Scallon, B. J., Ghrayeb, J., Forman, M. A., Montefiori, D. C., Rieber, E. P., Letvin, N. L., & Reimann, K. A.
- Venue
- Science
- Published
- 1999-02-05
- Volume
- 283
- Issue
- 5403
- Pages
- 857-860
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2144882745
- Cited by
- 2,187
- References
- 10
- FWCI
- 45.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.